179 related articles for article (PubMed ID: 38012105)
1. Meta-Analysis Global Group in Chronic Heart Failure score for the prediction of mortality in valvular heart disease.
Lv J; Xu H; Ye Y; Li Z; Wang W; Zhang B; Zhao Q; Zhang H; Zhao Z; Liu Q; Wang B; Duan Z; Yu Z; Guo S; Zhao Y; Gao R; Ge J; Wu Y;
ESC Heart Fail; 2024 Feb; 11(1):349-365. PubMed ID: 38012105
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide in Elderly Patients With Valvular Heart Disease.
Zhang B; Xu H; Zhang H; Liu Q; Ye Y; Hao J; Zhao Q; Qi X; Liu S; Zhang E; Xu Y; Gao R; Pibarot P; Clavel MA; Wu Y;
J Am Coll Cardiol; 2020 Apr; 75(14):1659-1672. PubMed ID: 32273031
[TBL] [Abstract][Full Text] [Related]
3. Assessment of cardio-renal-hepatic function in patients with valvular heart disease: a multi-biomarker approach-the cardio-renal-hepatic score.
Lv J; Zhang B; Ye Y; Li Z; Wang W; Zhao Q; Liu Q; Zhao Z; Zhang H; Wang B; Yu Z; Duan Z; Guo S; Zhao Y; Gao R; Xu H; Wu Y;
BMC Med; 2023 Jul; 21(1):257. PubMed ID: 37455313
[TBL] [Abstract][Full Text] [Related]
4. Meta-Analysis Global Group in Chronic (MAGGIC) Heart Failure Risk Score: Validation of a Simple Tool for the Prediction of Morbidity and Mortality in Heart Failure With Preserved Ejection Fraction.
Rich JD; Burns J; Freed BH; Maurer MS; Burkhoff D; Shah SJ
J Am Heart Assoc; 2018 Oct; 7(20):e009594. PubMed ID: 30371285
[TBL] [Abstract][Full Text] [Related]
5. Validation of the MAGGIC (Meta-Analysis Global Group in Chronic Heart Failure) heart failure risk score and the effect of adding natriuretic peptide for predicting mortality after discharge in hospitalized patients with heart failure.
Khanam SS; Choi E; Son JW; Lee JW; Youn YJ; Yoon J; Lee SH; Kim JY; Ahn SG; Ahn MS; Kang SM; Baek SH; Jeon ES; Kim JJ; Cho MC; Chae SC; Oh BH; Choi DJ; Yoo BS
PLoS One; 2018; 13(11):e0206380. PubMed ID: 30485284
[TBL] [Abstract][Full Text] [Related]
6. Contemporary Presentation and Management of Valvular Heart Disease: The EURObservational Research Programme Valvular Heart Disease II Survey.
Iung B; Delgado V; Rosenhek R; Price S; Prendergast B; Wendler O; De Bonis M; Tribouilloy C; Evangelista A; Bogachev-Prokophiev A; Apor A; Ince H; Laroche C; Popescu BA; Piérard L; Haude M; Hindricks G; Ruschitzka F; Windecker S; Bax JJ; Maggioni A; Vahanian A;
Circulation; 2019 Oct; 140(14):1156-1169. PubMed ID: 31510787
[TBL] [Abstract][Full Text] [Related]
7. Prevalence, Characteristics, and Outcomes of Valvular Heart Disease in Patients With Atrial Fibrillation: Insights From the ORBIT-AF (Outcomes Registry for Better Informed Treatment for Atrial Fibrillation).
Thomas KL; Jackson LR; Shrader P; Ansell J; Fonarow GC; Gersh B; Kowey PR; Mahaffey KW; Singer DE; Thomas L; Piccini JP; Peterson ED
J Am Heart Assoc; 2017 Dec; 6(12):. PubMed ID: 29273635
[TBL] [Abstract][Full Text] [Related]
8. Impact of Valvular Heart Disease on Mortality, Thromboembolic and Cardiac Events in Japanese Patients With Atrial Fibrillation - The Fushimi AF Registry.
Doi K; Ogawa H; Ishigami K; Ikeda S; Aono Y; Hamatani Y; Fujino A; An Y; Ishii M; Iguchi M; Masunaga N; Esato M; Tsuji H; Wada H; Hasegawa K; Abe M; Akao M;
Circ J; 2020 Apr; 84(5):714-722. PubMed ID: 32213725
[TBL] [Abstract][Full Text] [Related]
9. MAGGIC, STS, and EuroSCORE II Risk Score Comparison After Aortic and Mitral Valve Surgery.
Zhuo DX; Bilchick KC; Shah KP; Mehta NK; Mwansa H; Nkanza-Kabaso K; Kwon Y; Breathett KK; Hilton-Buchholz EJ; Mazimba S
J Cardiothorac Vasc Anesth; 2021 Jun; 35(6):1806-1812. PubMed ID: 33349502
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Impact of Left Ventricular Ejection Fraction in Patients With Moderate Aortic Regurgitation: Potential Implications for Treatment Decision-Making.
Zhao Q; Zhang B; Ye Y; Li Z; Liu Q; Zhao R; Zhao Z; Wang W; Yu Z; Zhang H; Duan Z; Wang B; Lv J; Guo S; Zhao Y; Gao R; Xu H; Wu Y
Front Cardiovasc Med; 2021; 8():800961. PubMed ID: 35111828
[TBL] [Abstract][Full Text] [Related]
11. Prognostic implications of valvular heart disease in patients with non-valvular atrial fibrillation.
Samaras A; Vrana E; Kartas A; Moysidis DV; Papazoglou AS; Doundoulakis I; Fotos G; Rampidis G; Tsalikakis DG; Efthimiadis G; Karvounis H; Tzikas A; Giannakoulas G
BMC Cardiovasc Disord; 2021 Sep; 21(1):453. PubMed ID: 34536990
[TBL] [Abstract][Full Text] [Related]
12. Validation of the Meta-Analysis Global Group in Chronic Heart Failure risk score for the prediction of 1-year mortality in a Chinese cohort.
Xu D; Dong Y; Zhang B; Li L; Jiang C
Chin Med J (Engl); 2022 Dec; 135(23):2829-2835. PubMed ID: 36728514
[TBL] [Abstract][Full Text] [Related]
13. Prognostic impact of moderate mitral regurgitation on hospitalized heart failure patients with preserved ejection fraction: A report from the JASPER registry.
Oikawa M; Yoshihisa A; Sato Y; Nagai T; Yoshikawa T; Saito Y; Yamamoto K; Takeishi Y; Anzai T
Heart Vessels; 2020 Aug; 35(8):1087-1094. PubMed ID: 32193620
[TBL] [Abstract][Full Text] [Related]
14. Performance of the MAGGIC heart failure risk score and its modification with the addition of discharge natriuretic peptides.
Sawano M; Shiraishi Y; Kohsaka S; Nagai T; Goda A; Mizuno A; Sujino Y; Nagatomo Y; Kohno T; Anzai T; Fukuda K; Yoshikawa T
ESC Heart Fail; 2018 Aug; 5(4):610-619. PubMed ID: 29520978
[TBL] [Abstract][Full Text] [Related]
15. Risk Prediction in Transition: MAGGIC Score Performance at Discharge and Incremental Utility of Natriuretic Peptides.
Michaels A; Aurora L; Peterson E; Liu B; Pinto YM; Sabbah HN; Williams K; Lanfear DE
J Card Fail; 2020 Jan; 26(1):52-60. PubMed ID: 31751788
[TBL] [Abstract][Full Text] [Related]
16. Distribution, Characteristics, and Management of Older Patients With Valvular Heart Disease in China: China-DVD Study.
Xu H; Liu Q; Cao K; Ye Y; Zhang B; Li Z; Hao J; Qi X; Zhao Q; Liu S; Gao R; Wu Y;
JACC Asia; 2022 Jun; 2(3):354-365. PubMed ID: 36338396
[TBL] [Abstract][Full Text] [Related]
17. Stages of Valvular Heart Disease Among Older Adults in the Community: The Atherosclerosis Risk in Communities Study.
Shelbaya K; Claggett B; Dorbala P; Skali H; Solomon SD; Matsushita K; Konety S; Mosley TH; Shah AM
Circulation; 2023 Feb; 147(8):638-649. PubMed ID: 36524478
[TBL] [Abstract][Full Text] [Related]
18. Incremental Prognostic Utility of Left Ventricular Global Longitudinal Strain in Asymptomatic Patients With Significant Chronic Aortic Regurgitation and Preserved Left Ventricular Ejection Fraction.
Alashi A; Mentias A; Abdallah A; Feng K; Gillinov AM; Rodriguez LL; Johnston DR; Svensson LG; Popovic ZB; Griffin BP; Desai MY
JACC Cardiovasc Imaging; 2018 May; 11(5):673-682. PubMed ID: 28624411
[TBL] [Abstract][Full Text] [Related]
19. Characteristics, management, and outcomes of patients with multiple native valvular heart disease: a substudy of the EURObservational Research Programme Valvular Heart Disease II Survey.
Tribouilloy C; Bohbot Y; Kubala M; Ruschitzka F; Popescu B; Wendler O; Laroche C; Bartha E; Ince H; Simkova I; Vahanian A; Iung B
Eur Heart J; 2022 Aug; 43(29):2756-2766. PubMed ID: 35511056
[TBL] [Abstract][Full Text] [Related]
20. Serum potassium levels provide prognostic information in symptomatic heart failure beyond traditional clinical variables.
Toledo CC; Vellosa Schwartzmann P; Miguel Silva L; da Silva Ferreira G; Bianchini Cardoso F; Citelli Ribeiro V; Paim LR; Antunes-Correa LM; Carvalho Sposito A; Matos Souza JR; Modolo R; Nadruz W; Fernandes de Carvalho LS; Coelho-Filho OR
ESC Heart Fail; 2021 Jun; 8(3):2133-2143. PubMed ID: 33734611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
